Heart Test Laboratories-CW27HSCSWPreferred / convertible
13F holders, Q2 2024 (June 30)5holders
2new positions
2sold out
1famous investor
$0.04avg. 13F price*
At the end of Q2 2024, 5 institutions reported holding Heart Test Laboratories-CW27 (HSCSW) in their 13F filings, unchanged from Q1 2024. 2 opened new positions and 2 sold out. The largest holders were Citadel Advisors ($11K), Clear Street LLC ($9K) and Susquehanna International Group, LLP ($2K). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Heart Test Laboratories-CW27
- CUSIP
- 42254E112
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $2K |
| Exits | 2 | $19K |
All 13F filers, Q1 2024 → Q2 2024: 234,462 shares bought and 365,883 shares sold, net −131,421 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Citadel Advisors | — | Add +685.0% | 224,328 | $11K |
| Clear Street LLC | — | Add +1.4% | 269,879 | $9K |
| Susquehanna International Group, LLP | — | New | 30,959 | $2K |
| UBS Group AG | — | New | 3,439 | $117 |
| Bank of America Corp. | — | Add +794.3% | 787 | $26 |
"% of holder's portfolio" is HSCSW's weight in each manager's 13F, not the share of Heart Test Laboratories-CW27 the manager owns.